The Annals New | Pharmaco Epidemiology and Therapeutic Risk Management
home help contact us subscription past issues search current issue
QUICK SEARCH:   [advanced]


     

The Annals of Pharmacotherapy: Vol. 27, No. 4, pp. 427-430.
© 1993 Harvey Whitney Books Company.
This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Articles Ahead of Print
Right arrow [Order Reprint]
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lopez-Gil, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lopez-Gil, J.

Research Articles

Fluconazole-cyclosporine interaction: a dose-dependent effect?

JA Lopez-Gil

OBJECTIVE: To present cases supporting the hypothesis that fluconazole inhibition of cyclosporine metabolism is dose-dependent. DESIGN: Case reports. PATIENTS AND INTERVENTIONS: One renal-pancreatic transplant patient taking fluconazole 100 and 300 mg/d for 37 and 17 days, respectively; four bone marrow transplant recipients taking fluconazole 100 mg/d as antifungal prophylaxis and five other concurrent nonmatched recipients whose antifungal prophylactic agent is nystatin mouthwash. All of these patients underwent transplantation during the same period. RESULTS: There was a sharp rise in cyclosporine trough concentration (ng/mL), concentration:dose ratio (ng.mL-1/mg.kg-1), and serum creatinine concentration (mumol/L) in the renal-pancreatic transplantation patient taking fluconazole 300 mg/d. No such increase occurred at 100 mg/d. No significant alterations in cyclosporine concentration:dose ratio were seen in the patients undergoing bone marrow transplantation and receiving fluconazole 100 mg/d. CONCLUSIONS: The case of the renal-pancreatic transplantation patient shows a characteristic interaction profile, and it supports the hypothesis of a dose-dependent interaction between cyclosporine and fluconazole. Given the nephrotoxic potential of the immunosuppressant drug, dosage reduction and closer monitoring of cyclosporine concentrations and/or renal function in patients receiving fluconazole dosages greater than 200 mg/d must be considered.


This article has been cited by other articles:


Home page
 CirculationHome page
R. L. Page II, G. G. Miller, and J. Lindenfeld
Drug Therapy in the Heart Transplant Recipient: Part IV: Drug-Drug Interactions
Circulation, January 18, 2005; 111(2): 230 - 239.
[Full Text] [PDF]

Home page
 Nephrol Dial TransplantHome page
T. Ideura, T. Muramatsu, M. Higuchi, N. Tachibana, K. Hora, and K. Kiyosawa
Tacrolimus/itraconazole interactions: a case report of ABO-incompatible living-related renal transplantation
Nephrol. Dial. Transplant., October 1, 2000; 15(10): 1721 - 1723.
[Full Text] [PDF]

Home page
 NEJMHome page
J. A. Como and W. E. Dismukes
Oral Azole Drugs as Systemic Antifungal Therapy
N. Engl. J. Med., January 27, 1994; 330(4): 263 - 272.
[Full Text]


homecopy help contact us subscription past issues search current issue
Copyright © 1993 by Harvey Whitney Books Company.